Login / Signup

The use of dostarlimab, a safe and efficient monotherapy in MSI-H rectal cancer patients, an alternative to surgery.

Yara BazMaria RassamElsa RhayemJoseph ZoueinJoseph GhariosHampig Raphael Kourie
Published in: Immunotherapy (2023)
Keyphrases
  • minimally invasive
  • coronary artery bypass
  • combination therapy
  • surgical site infection
  • rectal cancer
  • open label
  • acute coronary syndrome